| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.54 | 0.05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.24 | 0.06 |